can you give nitrofurantoin and augmentin together for fever with uti
Reading File
Finding Sources
Finding Sources
Searching PubMed
nitrofurantoin amoxicillin clavulanate urinary tract infection combination
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Here is a clear, evidence-based answer:
Nitrofurantoin + Augmentin (Amoxicillin-Clavulanate) for Febrile UTI
Short answer: This combination is generally not recommended, and the clinical scenario of fever with UTI specifically argues against using nitrofurantoin at all.
Why Fever Changes the Picture
Fever with UTI should be presumed pyelonephritis (upper urinary tract infection) until proven otherwise. This is the critical distinction:
"Nitrofurantoin and fosfomycin do not achieve adequate blood and tissue levels and therefore are not effective for pyelonephritis." — Rosen's Emergency Medicine, Chapter 85
Nitrofurantoin works only as a urinary antiseptic — it achieves high urine concentrations but is rapidly metabolized so that no systemic or tissue levels are reached. The textbook explicitly states:
"The drug should not be used to treat upper urinary tract infection due to inadequate drug levels." — Katzung's Basic & Clinical Pharmacology, 16th Ed.
What About the Combination?
There is no established clinical rationale for combining nitrofurantoin with amoxicillin-clavulanate:
- Nitrofurantoin covers lower UTI pathogens (mainly E. coli) in the bladder only.
- Augmentin (amoxicillin-clavulanate) has broad-spectrum coverage including upper tract tissue levels and can be used as monotherapy for UTI.
- Combining them does not provide additive benefit for pyelonephritis; it only adds cost, adverse effects, and complexity.
- There is no synergy between them, and resistance spectra do not complement each other in a clinically meaningful way.
For UTI in pregnancy specifically, Rosen's lists amoxicillin-clavulanate or nitrofurantoin as separate monotherapy options — not combined.
What Should Be Used for Febrile UTI (Pyelonephritis)?
| Severity | Preferred Agents |
|---|---|
| Mild–moderate outpatient pyelonephritis | Ciprofloxacin 7 days (if fluoroquinolone resistance <10%), or TMP-SMX 10–14 days, or oral cephalosporin |
| Severe / hospitalized | IV cefepime, ceftriaxone, piperacillin-tazobactam, or aztreonam → transition to oral after afebrile 24–48 h; total 10–14 days |
| Pregnancy + pyelonephritis | IV ceftriaxone, cefepime, aztreonam, or pip-tazo (fluoroquinolones avoided) |
Augmentin alone can be used for uncomplicated lower UTI (especially in pregnancy), but it is not a first-line agent for pyelonephritis in most guidelines.
Bottom Line
| Agent | Uncomplicated Cystitis (no fever) | Febrile UTI / Pyelonephritis |
|---|---|---|
| Nitrofurantoin | ✅ First-line | ❌ Contraindicated — no tissue levels |
| Augmentin | ✅ Acceptable (esp. pregnancy) | ⚠️ Not preferred but achieves tissue levels |
| Combination of both | ❌ No indication | ❌ No indication |
If a patient has fever + UTI, nitrofurantoin should be stopped or not started, and a systemic antibiotic (fluoroquinolone, cephalosporin, or TMP-SMX) used as monotherapy based on local resistance patterns and culture results. — Rosen's Emergency Medicine; Katzung's Basic & Clinical Pharmacology, 16th Ed.
This is a shared conversation. Sign in to Orris to start your own chat.